Ad
related to: blood platelet count
Search results
Donate blood during 'Trauma Awareness Month'
The Eagle-Tribune· 5 days agoMANCHESTER — When every second counts, blood products can provide lifesaving care. The American Red Cross asks the public to give blood or platelets...
Build the blood supply: Give blood or platelets now with Red Cross
Your Hometown Lima Stations· 3 days agoMay 20, 2024, Press Release from The American Red Cross: INDIANA, May 20, 2024 — Late May signals...
'I suffered a stroke after my AstraZeneca Covid vaccine'
Daily Express· 6 days agoAstraZeneca has since said that thrombocytopenia syndrome can be a “rare” side effect of the...
Systemic juvenile arthritis: Symptoms, health effects, and more
Medical News Today· 4 days agoSystemic juvenile idiopathic arthritis (SJIA), or “Still’s disease,” is a rare autoinflammatory...
AstraZeneca Admits Covishield Vaccine Can Cause Rare Side Effects, What Is TTS?
Homenewshere.com· 2 days agoAstraZeneca has acknowledged that its Covid vaccine, Covishield, can cause a rare side effect called...
Red Cross seeks to build blood supply before busy summer season
Gannett via AOL· 3 days agoLate May signals the beginning of a busy time for celebrations and summer holidays. The American Red Cross asks donors to make an appointment to give blood or platelets ...
WMUR Statewide Blood Drive set for June 7; learn how you can help
WMUR New Hampshire· 3 days agoWMUR is sponsoring a blood drive on Friday, June 7, 2024, along with the American Red Cross. Learn...
Statins for cholesterol control: Benefits, risks, and more
Medical News Today· 2 days agoStatins are a class of medications that reduce cholesterol levels in the blood, especially...
Blood RNA Biomarkers Identify Bacterial and Biofil | Newswise
Newswise· 4 days agoAbstract Purpose: Secondary opportunistic coinfections are a significant contributor to morbidity and mortality in intensive care unit (ICU) patients
Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
FOX21 Colorado Springs· 6 hours agoOral presentation of final five-year results from the registrational Phase 2 trial in R/R mIDH1 AML patients reinforces REZLIDHIA® (olutasidenib) efficacy in heavily pretreated patients, including ...
